Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CBS | P35520 | 2/20 | 0.78 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.78 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.78 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.72 |
| ▸ | PKM | P14618 | 4/20 | 0.72 |
| ▸ | MAPT | P10636 | 4/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.72 |
| ▸ | APEX1 | P27695 | 3/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.72 |
| ▸ | POLB | P06746 | 2/20 | 0.72 |
| ▸ | RECQL | P46063 | 2/20 | 0.72 |
| ▸ | BLM | P54132 | 2/20 | 0.72 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.72 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.72 |
| ▸ | ALPL | P05186 | 1/20 | 0.72 |
| ▸ | ALPI | P09923 | 1/20 | 0.72 |
| ▸ | GAA | P10253 | 1/20 | 0.72 |
| ▸ | ALPG | P10696 | 1/20 | 0.72 |
| ▸ | PFKFB3 | Q16875 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29435853 | 1.00 | CBS (0.78) | CBSCDK5CDK5R1PTPN1KMT2A | |
| SCHEMBL28986431 | 1.00 | CBS (0.78) | CBSCDK5CDK5R1PTPN1KMT2A | |
| Cupressuflavone SCHEMBL31670258 | 0.88 | CBS (1.00) | CBSCDK5CDK5R1PTPN1KMT2A | |
| Cupressuflavone SCHEMBL505213 | 0.88 | CBS (1.00) | CBSCDK5CDK5R1PTPN1KMT2A | |
| Norwogonin SCHEMBL30485998 | 0.88 | GABRP (0.68) | CBSCDK5CDK5R1PTPN1KMT2A | |
| SCHEMBL24840880 | 0.88 | KMT2A (0.72) | CBSCDK5CDK5R1PTPN1KMT2A | |
| Norwogonin SCHEMBL760431 | 0.88 | GABRP (0.68) | CBSCDK5CDK5R1PTPN1KMT2A | |
| Cupressuflavone SCHEMBL4650575 | 0.86 | CBS (0.97) | CBSCDK5CDK5R1PTPN1KMT2A | |
| Hypolaetin SCHEMBL29929136 | 0.86 | BCL2 (0.69) | CBSCDK5CDK5R1PTPN1KMT2A | |
| Hypolaetin SCHEMBL29435843 | 0.86 | BCL2 (0.69) | CBSCDK5CDK5R1PTPN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| WO-2024220449-A9 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2025-04-03 | — | — | WO | claimed |
| US-20250011393-A1 | FLAVONOID-COLLAGEN CROSSLINKED ANTIOXIDANT HYDROGEL | NORTH CAROLINA STATE UNIVERSITY | 2025-01-09 | — | — | US | claimed |
| WO-2024220449-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | ASKLEPIOS BIOPHARMACEUTICAL, INC. (US) | 2024-10-24 | — | — | WO | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| CN-113046333-B | Flavone-8-hydroxylase and application thereof in synthesis of 8-hydroxyflavone compound | 中国科学院天津工业生物技术研究所 | 2023-02-17 | — | — | CN | claimed |
| CN-114166961-B | Method for measuring phenolic compounds in citrus juice product and pretreatment method thereof | 西南大学 | 2022-11-22 | — | — | CN | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| CN-113046333-A | Flavone-8-hydroxylase and application thereof in synthesis of 8-hydroxyflavone compound | 中国科学院天津工业生物技术研究所 | 2021-06-29 | — | — | CN | claimed |
| WO-2001085183-A2 | PREPARATION FOR THE PREVENTION AND TREATMENT OF OCULAR DISORDERS | N.V. NUTRICIA (NL) | 2001-11-15 | — | — | WO | claimed |
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | disclosed |
| US-20250161394-A1 | Compositions Comprising Kavalactones | NATURAL EXTRACTION SYS LLC (US) | 2025-05-22 | — | — | US | disclosed |
| US-5773462-A | INFLUENZA THERAPY | MEDICHEM RESEARCH, INC. (US) | 1998-06-30 | — | — | US | disclosed |
| EP-0833631-A1 | BIFLAVANOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS | MEDICHEM RESEARCH, INC. (US) | 1998-04-08 | — | — | EP | disclosed |
| WO-1997000679-A1 | BIFLAVANOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS | MEDICHEM RESEARCH, INC. (US) | 1997-01-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | CBS 1497/4885CDK5 890/4885CDK5R1 924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.